DIA 2018 Global Annual Meeting

Findings of a recently conducted Sanofi / PAREXEL study on the evaluation and technical implementation of novel ‘wearable’ medical devices as additional patient evaluation tools in pre-and post-approval clinical studies with be presented in context to key learnings and insights on the application of wearables-related RWD across the clinical development spectrum. The practical implications of innovation are tested with guidance on the right balance of risk mitigation and development innovation.